Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism
NCT07466381
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
oxyhydrogen nanobubble infusion
Sponsor
dr. Siti Nurlaela, SpN